{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:42:11Z","timestamp":1784522531088,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"VHA Health Services Research and Development Quality Enhancement Research Initiative","award":["Partnered Evaluation Initiatives 18-203 and 19-001"],"award-info":[{"award-number":["Partnered Evaluation Initiatives 18-203 and 19-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06722-6","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T10:34:37Z","timestamp":1742985277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration"],"prefix":"10.1186","volume":"25","author":[{"given":"Madeline C.","family":"Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Malte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildi J.","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Trim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Lott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa N.","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"2","key":"6722_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","volume":"76","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry. 2019;76(2):208\u201316.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"6722_CR2","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"6722_CR3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","volume":"115","author":"N Krawczyk","year":"2020","unstructured":"Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, et al. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction. 2020;115(9):1683\u201394.","journal-title":"Addiction"},{"key":"6722_CR4","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Accessed March 17, 2022 at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf. 2021."},{"key":"6722_CR5","doi-asserted-by":"crossref","unstructured":"Hedegaard H, Mini\u00f1o A, Spencer M, Warner M. Drug Overdose Deaths in the United States, 1999\u20132020. NCHS Data Brief No. 428. Centers for Disease Control and Prevention. Accessed January 7, 2022 from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db428.htm. 2021.","DOI":"10.15620\/cdc:112340"},{"key":"6722_CR6","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. Accessed January 21, 2023 at: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. 2023."},{"issue":"1","key":"6722_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-021-00218-w","volume":"16","author":"CI Campbell","year":"2021","unstructured":"Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, et al. PRimary care opioid use disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021;16(1):9.","journal-title":"Addict Sci Clin Pract"},{"key":"6722_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2019.07.013","volume":"108","author":"GM Miele","year":"2020","unstructured":"Miele GM, Caton L, Freese TE, McGovern M, Darfler K, Antonini VP, et al. Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact. J Subst Abuse Treat. 2020;108:20\u20135.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"6722_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","volume":"166","author":"PT Korthuis","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary Care-Based models for the treatment of opioid use disorder: A scoping review. Ann Intern Med. 2017;166(4):268\u201378.","journal-title":"Ann Intern Med"},{"issue":"1","key":"6722_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13722-018-0127-z","volume":"13","author":"H Hagedorn","year":"2018","unstructured":"Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, et al. Advancing Pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addict Sci Clin Pract. 2018;13(1):25.","journal-title":"Addict Sci Clin Pract"},{"key":"6722_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.010","volume":"70","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Britt J, Cucciare MA. Transitioning from detoxification to substance use disorder treatment: facilitators and barriers. J Subst Abuse Treat. 2016;70:64\u201372.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"6722_CR12","first-page":"327","volume":"35","author":"DR Pating","year":"2012","unstructured":"Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis DM. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatric Clin. 2012;35(2):327\u201356.","journal-title":"Psychiatric Clin"},{"issue":"3","key":"6722_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/00952990.2021.1992773","volume":"48","author":"AJ Cotton","year":"2022","unstructured":"Cotton AJ, Lo K, Kurtz FB, Waldbauer L. Extended-release buprenorphine outcomes among treatment resistant veterans. Am J Drug Alcohol Abus. 2022;48(3):334\u20137.","journal-title":"Am J Drug Alcohol Abus"},{"issue":"5","key":"6722_CR14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","volume":"39","author":"H Samples","year":"2020","unstructured":"Samples H, Williams AR, Crystal S, Olfson M. Impact of Long-Term buprenorphine treatment on adverse health care outcomes in medicaid: the impact of longer treatment on health care outcomes for opioid use disorder within a key population of medicaid enrollees. Health Aff (Millwood). 2020;39(5):747\u201355.","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"6722_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2013.10.014","volume":"46","author":"J Tkacz","year":"2014","unstructured":"Tkacz J, Volpicelli J, Un H, Ruetsch C. Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients. J Subst Abuse Treat. 2014;46(4):456\u201362.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"6722_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","volume":"177","author":"AR Williams","year":"2020","unstructured":"Williams AR, Samples H, Crystal S, Olfson M. Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder. Am J Psychiatry. 2020;177(2):117\u201324.","journal-title":"Am J Psychiatry"},{"key":"6722_CR17","doi-asserted-by":"crossref","unstructured":"Ronquest NA, Willson TM, Montejano LB, Nadipelli VR, Wollschlaeger BA. Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Subst Abuse Rehabilitation. 2018:59\u201378.","DOI":"10.2147\/SAR.S150253"},{"issue":"4","key":"6722_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jsat.2012.03.008","volume":"43","author":"R Schwarz","year":"2012","unstructured":"Schwarz R, Zelenev A, Bruce RD, Altice FL. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. J Subst Abuse Treat. 2012;43(4):451\u20137.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"6722_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/add.13270","volume":"111","author":"WH Lo-Ciganic","year":"2016","unstructured":"Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, et al. Association between trajectories of buprenorphine treatment and emergency department and in\u2010patient utilization. Addiction. 2016;111(5):892\u2013902.","journal-title":"Addiction"},{"issue":"4","key":"6722_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/pop.2018.0163","volume":"22","author":"Y-J Hsu","year":"2019","unstructured":"Hsu Y-J, Marsteller JA, Kachur SG, Fingerhood MI. Integration of buprenorphine treatment with primary care: comparative effectiveness on retention, utilization, and cost. Popul Health Manage. 2019;22(4):292\u20139.","journal-title":"Popul Health Manage"},{"key":"6722_CR21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11606-018-4807-x","volume":"34","author":"SE Wakeman","year":"2019","unstructured":"Wakeman SE, Rigotti NA, Chang Y, Herman GE, Erwin A, Regan S, et al. Effect of integrating substance use disorder treatment into primary care on inpatient and emergency department utilization. J Gen Intern Med. 2019;34:871\u20137.","journal-title":"J Gen Intern Med"},{"key":"6722_CR22","doi-asserted-by":"crossref","first-page":"111350","DOI":"10.1016\/j.drugalcdep.2024.111350","volume":"261","author":"JF Bobb","year":"2024","unstructured":"Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, et al. Offering nurse care management for opioid use disorder in primary care: impact on emergency and hospital utilization in a cluster-randomized implementation trial. Drug Alcohol Depend. 2024;261:111350.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"6722_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","volume":"39","author":"JJ Wyse","year":"2018","unstructured":"Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, et al. Medications for opioid use disorder in the department of veterans affairs (VA) health care system: historical perspective, lessons learned, and next steps. Subst Abus. 2018;39(2):139\u201344.","journal-title":"Subst Abus"},{"issue":"3","key":"6722_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","volume":"41","author":"AJ Gordon","year":"2020","unstructured":"Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, et al. Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within veterans health administration facilities. Subst Abus. 2020;41(3):275\u201382.","journal-title":"Subst Abus"},{"issue":"12","key":"6722_CR25","doi-asserted-by":"crossref","first-page":"e2137238","DOI":"10.1001\/jamanetworkopen.2021.37238","volume":"4","author":"EJ Hawkins","year":"2021","unstructured":"Hawkins EJ, Malte CA, Gordon AJ, Williams EC, Hagedorn HJ, Drexler K, et al. Accessibility to medication for opioid use disorder after interventions to improve prescribing among nonaddiction clinics in the US veterans health care system. JAMA Netw Open. 2021;4(12):e2137238.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"6722_CR26","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ije\/dyy135","volume":"47","author":"J Lopez Bernal","year":"2018","unstructured":"Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018;47(6):2082\u201393.","journal-title":"Int J Epidemiol"},{"key":"6722_CR27","doi-asserted-by":"crossref","first-page":"107732","DOI":"10.1016\/j.drugalcdep.2019.107732","volume":"207","author":"G Lapham","year":"2020","unstructured":"Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207:107732.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"6722_CR28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3122\/jabfm.2019.05.190012","volume":"32","author":"RE Cantone","year":"2019","unstructured":"Cantone RE, Garvey B, O\u2019Neill A, Fleishman J, Cohen D, Muench J, et al. Predictors of medication-assisted treatment initiation for opioid use disorder in an interdisciplinary primary care model. J Am Board Fam Med. 2019;32(5):724\u201331.","journal-title":"J Am Board Fam Med"},{"issue":"11","key":"6722_CR29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"6722_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299\u2013309.","journal-title":"J Clin Pharm Ther"},{"key":"6722_CR31","doi-asserted-by":"crossref","first-page":"209175","DOI":"10.1016\/j.josat.2023.209175","volume":"155","author":"MC Frost","year":"2023","unstructured":"Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. J Subst Use Addict Treat. 2023;155:209175.","journal-title":"J Subst Use Addict Treat"},{"key":"6722_CR32","unstructured":"StataCorp. Stata statistical software: release 18, college station. TX: StataCorp LLC; 2023."},{"key":"6722_CR33","doi-asserted-by":"crossref","unstructured":"Oliva EM, Christopher ML, Wells D, Bounthavong M, Harvey M, Himstreet J, et al. Opioid overdose education and Naloxone distribution: development of the veterans health administration\u2019s National program. J Am Pharm Assoc (2003). 2017;57(2S):S168\u201379. e4.","DOI":"10.1016\/j.japh.2017.01.022"},{"issue":"5","key":"6722_CR34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","volume":"158","author":"LA Lin","year":"2017","unstructured":"Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833\u20139.","journal-title":"Pain"},{"issue":"1","key":"6722_CR35","first-page":"26","volume":"18","author":"MC Frost","year":"2023","unstructured":"Frost MC, Soyer EM, Achtmeyer CA, Hawkins EJ, Glass JE, Hallgren KA, et al. Treating opioid use disorder in veterans with co-occurring substance use: A qualitative study with buprenorphine providers in primary care, mental health, and pain settings addict. Sci Clin Pract. 2023;18(1):26.","journal-title":"Sci Clin Pract"},{"issue":"2","key":"6722_CR36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","volume":"36","author":"SR Mueller","year":"2015","unstructured":"Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and Naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240\u201353.","journal-title":"Subst Abus"},{"issue":"5","key":"6722_CR37","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312. Health Aff (Millwood). 2016;35(5):832\u20137.","journal-title":"Health Aff (Millwood)"},{"key":"6722_CR38","doi-asserted-by":"crossref","first-page":"109132","DOI":"10.1016\/j.drugalcdep.2021.109132","volume":"229","author":"WQ Gan","year":"2021","unstructured":"Gan WQ, Buxton JA, Scheuermeyer FX, Palis H, Zhao B, Desai R, et al. Risk of cardiovascular diseases in relation to substance use disorders. Drug Alcohol Depend. 2021;229:109132.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"6722_CR39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","volume":"380","author":"ASB Bohnert","year":"2019","unstructured":"Bohnert ASB, Ilgen MA. Understanding links among opioid use, overdose, and suicide. N Engl J Med. 2019;380(1):71\u20139.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"6722_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","volume":"103","author":"SS Martins","year":"2009","unstructured":"Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use\/dependence and psychiatric disorders: results from the National epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2009;103(1\u20132):16\u201324.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06722-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T10:35:51Z","timestamp":1742985351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06722-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6722"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06722-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Per VHA policy (VHA Program Guide 1200.21) this evaluation was designated as a quality improvement project and received a non-research determination from the VHA Office of Mental Health and Suicide Prevention, and therefore did not require institutional review board oversight. The evaluation used secondary electronic health record data and therefore did not consent participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AJS receives royalties from UpToDate, Inc. No other disclosures are reported by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}